glp-1 shortages The boom created one of the strangest health stories of the decade. Drugs built for diabetes and obesity became pop-culture products, then supply opened the door to falsified versions. WHO The GLP-1 drug shortage is
Description
Endocrinology 156 , 847857 (2014)

An earlier Clinical Practice Guidance joint statement made in October 2024 by multiple medical societies (American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) states that most patients should continue taking their GLP-1 drugs before elective surgery
[DOI] [PubMed] [Google Scholar] 85.Suzuki Y., et al

While the term is not yet a formal clinical diagnosis, it has gained significant traction among patients, dentists, and researchers as reports of dental side effects linked to GLP-1 medications continue to rise

No sublingual drops
For instance, if you weigh 150 pounds (68 kg), your daily protein target could range from 90 to 136 grams
